These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
549 related items for PubMed ID: 17218726
21. Abnormalities in bone mineral density distribution and bone scintigraphy in patients with childhood onset hypopituitarism. Kosowicz J, El Ali Z, Ziemnicka K, Sowinski J. J Clin Densitom; 2007; 10(3):332-9. PubMed ID: 17470407 [Abstract] [Full Text] [Related]
22. The effects of five-year growth hormone replacement therapy on muscle strength in elderly hypopituitary patients. Götherström G, Bengtsson BA, Sunnerhagen KS, Johannsson G, Svensson J. Clin Endocrinol (Oxf); 2005 Jan; 62(1):105-13. PubMed ID: 15638878 [Abstract] [Full Text] [Related]
24. Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults. Murray RD, Skillicorn CJ, Howell SJ, Lissett CA, Rahim A, Shalet SM. Clin Endocrinol (Oxf); 1999 Jun; 50(6):749-57. PubMed ID: 10468947 [Abstract] [Full Text] [Related]
25. One year of GH replacement therapy with a fixed low-dose regimen improves body composition, bone mineral density and lipid profile of GH-deficient adults. Boguszewski CL, Meister LH, Zaninelli DC, Radominski RB. Eur J Endocrinol; 2005 Jan; 152(1):67-75. PubMed ID: 15762189 [Abstract] [Full Text] [Related]
26. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency. Högler W, Briody J, Moore B, Lu PW, Cowell CT. Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578 [Abstract] [Full Text] [Related]
27. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy. Thorén M, Hilding A, Brismar T, Magnusson P, Degerblad M, Larsson L, Sääf M, Baylink DJ, Mohan S. J Bone Miner Res; 1998 May; 13(5):891-9. PubMed ID: 9610754 [Abstract] [Full Text] [Related]
28. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease. Fernholm R, Bramnert M, Hägg E, Hilding A, Baylink DJ, Mohan S, Thorén M. J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440 [Abstract] [Full Text] [Related]
29. Seven years of growth hormone (GH) replacement improves quality of life in hypopituitary patients with adult-onset GH deficiency. Elbornsson M, Horvath A, Götherström G, Bengtsson BÅ, Johannsson G, Svensson J. Eur J Endocrinol; 2017 Feb; 176(2):99-109. PubMed ID: 27803031 [Abstract] [Full Text] [Related]
30. Effect of growth hormone (GH) treatment on bone in postpubertal GH-deficient patients: a 2-year randomized, controlled, dose-ranging study. Shalet SM, Shavrikova E, Cromer M, Child CJ, Keller E, Zapletalová J, Moshang T, Blum WF, Chipman JJ, Quigley CA, Attanasio AF. J Clin Endocrinol Metab; 2003 Sep; 88(9):4124-9. PubMed ID: 12970274 [Abstract] [Full Text] [Related]
31. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement. Schneider HJ, Oertel H, Murck H, Pollmächer T, Stalla GK, Steiger A. Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440 [Abstract] [Full Text] [Related]
32. Long-term change in the bone mineral density of adults with adult onset growth hormone (GH) deficiency in response to short or long-term GH replacement therapy. Rahim A, Holmes SJ, Adams JE, Shalet SM. Clin Endocrinol (Oxf); 1998 Apr; 48(4):463-9. PubMed ID: 9640413 [Abstract] [Full Text] [Related]
33. Longitudinal changes of lumbar bone mineral density (BMD) in patients with GH deficiency after discontinuation of treatment at final height; timing and peak values for lumbar BMD. Baroncelli GI, Bertelloni S, Sodini F, Saggese G. Clin Endocrinol (Oxf); 2004 Feb; 60(2):175-84. PubMed ID: 14725678 [Abstract] [Full Text] [Related]
34. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass. Saggese G, Baroncelli GI, Bertelloni S, Barsanti S. J Clin Endocrinol Metab; 1996 Aug; 81(8):3077-83. PubMed ID: 8768878 [Abstract] [Full Text] [Related]
36. Effects of growth hormone replacement therapy on bone markers and bone mineral density in growth hormone-deficient adults. Nilsson AG. Horm Res; 2000 Aug; 54 Suppl 1():52-7. PubMed ID: 11146380 [Abstract] [Full Text] [Related]
37. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD. Lange M, Müller J, Svendsen OL, Kastrup KW, Juul A, Feldt-Rasmussen U. Clin Endocrinol (Oxf); 2005 Jan; 62(1):18-23. PubMed ID: 15638865 [Abstract] [Full Text] [Related]
38. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism. Colao A, Di Somma C, Pivonello R, Loche S, Aimaretti G, Cerbone G, Faggiano A, Corneli G, Ghigo E, Lombardi G. J Clin Endocrinol Metab; 1999 Jun; 84(6):1919-24. PubMed ID: 10372687 [Abstract] [Full Text] [Related]
39. The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism. Beshyah SA, Thomas E, Kyd P, Sharp P, Fairney A, Johnston DG. Clin Endocrinol (Oxf); 1994 Mar; 40(3):383-91. PubMed ID: 8187303 [Abstract] [Full Text] [Related]
40. Unreplaced sex steroid deficiency, corticotropin deficiency, and lower IGF-I are associated with lower bone mineral density in adults with growth hormone deficiency: a KIMS database analysis. Tritos NA, Greenspan SL, King D, Hamrahian A, Cook DM, Jönsson PJ, Wajnrajch MP, Koltowska-Häggstrom M, Biller BM. J Clin Endocrinol Metab; 2011 May; 96(5):1516-23. PubMed ID: 21367928 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]